Solex Energy Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/7sq2s7oiqayohygum90ic7fd.pdf

Key Takeaways


The OEM-Plus-Brand Model

Chetan Shah: “We don't mind manufacturing, even for our competitors also. In fact, that endorses our brand more, because whatever panel we manufacture for OEM also, there it is mentioned that it is manufactured by Solex.”

Capacity Build-Out & Execution

Chetan Shah: “We are very conservative when it comes to expansion, and it is going more by the business dynamics then rather than the expectation of the market or the other stakeholders.”

Margin Trajectory


Policy Backstop & Export Optionality

Chetan Shah: “With ALMM, there is no relevance of duty because even there is a duty, if somebody wants to pay duty and bring it, they cannot bring it. So, even if a duty remains or doesn't remain, it makes no difference.”

Cell Line: The High-Margin, High-Uncertainty Option

Vipul Shah: “DCR cells are sold at a very huge 16 cents, like when Chinese are being delivered the Chinese cells with the 4 cents. And the DCR cells are being sold at 16. So margin is clear, it says an extraordinary margin.”

EPC, Strategic Partners & Raw Material Shifts


Guidance & Commitments

CommitmentSpecificsTimeline
FY25 revenue₹800–900 Cr including ₹100 Cr EPCFY25
Full-year manufacturing revenue (both lines)₹1,300–1,400 Cr excluding EPCFirst full year with both lines operational
H1 FY25 revenue (first line only)₹275–300 CrH1 FY25
EBITDA margin9–11% (9% comfortable)Not dated; driven by utilisation and mix shift
Second production line startContribution from September–December onwardsH2 FY25
3 GW factory building ready for equipmentWithin six to nine monthsBy mid-2025
Own-brand mixShift from 30% toward 50%After second production line operational
Export shareUltimate target of 30% of revenueLong-term; no interim milestone given
U.S. market entryBreakthrough targeted this yearFY25
Cell line decisionContingent on Chinese engineer visa resolutionNo timeline; July China visit planned for developments

Key Metrics

MetricQ4 FY24
Revenue₹272 cr in H2 FY24, with H1 FY25 expected at ₹275–300 cr
EBITDA margin7.76% in FY24, with target of 9–11% going forward
Capacity utilisation80–90% in H2 FY24, operating three shifts, 28 days a month
Monthly module production50,000 modules average, with peak of 60,000 modules achieved
OEM vs own brand mix70:30 on volume, target to reach 50:50 after second line operational
EPC revenue₹50 cr in FY24, with order book of ~₹25 cr as of 31 March 2024
Total debt₹96 cr, of which term exposure is ~₹40 cr and rest is working capital
FY25 revenue guidance₹800–900 cr, including ₹100 cr EPC; full-year both lines target ₹1,300–1,400 cr excluding EPC
Second line CapEx₹70–75 cr, with ₹72 cr being raised via equity; 3 GW expansion requires additional ₹270 cr
ALMM models listed249 models, highest among all listed entities on ALMM
Export realisation premium~10% higher in U.S. versus India
DCR vs non-DCR module realisation₹9,000 for DCR, ₹7,500 for non-DCR per module
Job work billing₹18 cr in FY24, representing module value of ₹150 cr
EPC subsidiary stake76% held by Solex, with EPC business expected to reach ₹300 cr (100 MW)